Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias:: the case of antipsychotics

被引:22
作者
Calderone, V
Testai, L
Martinotti, E
Del Tacca, M
Breschi, MC
机构
[1] Univ Pisa, Dipartimento Psichiat Neurobiol Farmacol & Biotec, I-56126 Pisa, Italy
[2] Univ Pisa, Dipartimento Oncol Trapianti & Nuove Tecnol Med, I-56126 Pisa, Italy
关键词
D O I
10.1211/0022357055272
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The prolongation of the cardiac repolarization process, a result of the blocking of the Human Ether-ago-go Related Gene potassium channel, is an undesired accessory property shared by many pharmacological classes of non-cardiovascular drugs. Often the delayed cardiac repolarization process can be identified by a prolongation of the QT interval of the electrocardiograph. In these conditions, premature action potentials can trigger a dangerous polymorphic ventricular tachyarrhythmia, known as torsade de pointes, which occasionally can result in lethal ventricular fibrillation. in this work, brief descriptions of the electrophysiological basis of torsade de pointes and of the several pharmacological classes of torsadogenic drugs are given. Attention is focused on antipsychotics, with a deeper overview on the experimental and clinical reports about their torsadogenic properties.
引用
收藏
页码:151 / 161
页数:11
相关论文
共 97 条
[1]
IN-VITRO ELECTROPHYSIOLOGICAL DETECTION OF IATROGENIC ARRHYTHMOGENICITY [J].
ADAMANTIDIS, MM ;
KERRAM, P ;
DUPUIS, BA .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (05) :391-407
[2]
BAN TA, 1964, CAN MED ASSOC J, V91, P537
[3]
Bastecky J, 1990, Cesk Psychiatr, V86, P264
[4]
Cardiotoxicity associated with intentional ziprasidone and bupropion overdose [J].
Biswas, AK ;
Zabrocki, LA ;
Mayes, KL ;
Morris-Kukoski, CL .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2003, 41 (01) :81-84
[5]
Ziprasidone overdose [J].
Burton, S ;
Heslop, K ;
Harrison, K ;
Barnes, M .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (05) :835-835
[6]
Committee for Proprietary Medicinal Products (CPMP), 1997, CPMP98696 EUR AG EV
[7]
Committee on Safety of Medicines- Medicines Control Agency, 1995, CAN COMMUN DIS RE S3, V21, P1
[8]
Committee to Advise on Tropical Medicine and Travel (CATMAT), 2001, CAN COMMUN DIS REP, V27, P1
[9]
Czekalla J, 2001, J CLIN PSYCHIAT, V62, P35
[10]
Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis [J].
Czekalla, J ;
Beasley, CM ;
Dellva, MA ;
Berg, PH ;
Grundy, S .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (03) :191-198